Liver fibrosis test study for fatty liver disease
Part of Digestive system clinical trials.
This study is looking for new ways to detect liver scarring (fibrosis) in people with fatty liver disease (NAFLD, NASH, MASLD, or MASH). If you qualify, you will give a blood sample to help identify biomarkers that could replace biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or are suspected to have fatty liver disease (like NAFLD, NASH, MASLD, or MASH).
- You are scheduled for a liver biopsy or had one in the past 6 months.
- Your age is between 18 and 75 years old.
- Your BMI is 45 or lower.
- You do not have other liver diseases (like hepatitis, alcoholic liver disease, or autoimmune hepatitis) or active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a way to find liver scarring (fibrosis) early in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. Early detection may help prevent serious liver damage.
This study looks at how the liver's immune environment changes in people with non-alcoholic fatty liver disease (NAFLD) that has progressed to significant scarring. Researchers will use a liver biopsy to understand the inflammation better, which may lead to new treatments.
This trial uses a blood test (FIB-4) to find liver scarring (fibrosis) in people who haven't been tested before. It aims to catch advanced liver disease early, which can help you get treatment sooner.
This study compares two non-invasive approaches to diagnose advanced liver scarring in people with non-alcohol-related fatty liver disease (NAFLD). It may help confirm which test strategy finds advanced scarring without needing a biopsy for everyone.
This study uses a simple blood test to look for tiny particles from liver cells. It includes healthy volunteers, people with type 2 diabetes and liver scarring, and people with different stages of liver disease.
This study enrolls people with confirmed fatty liver to help researchers create and validate tests that may estimate liver scarring (fibrosis). It focuses on collecting medical information and verifying the liver condition using lab/scan results, which could help improve future care.
Hear when a new Non-alcoholic Fatty Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.